Zoonotic & Vector-Borne Diseases

>

Latest News

FDA Approves Bavarian Nordic’s Chikungunya Vaccine or Those 12 and Older
FDA Approves Bavarian Nordic’s Chikungunya Vaccine or Those 12 and Older

February 14th 2025

The approval is based on positive phase 3 clinical trial results, offering an effective option for travelers and others at risk of chikungunya, the mosquito-borne illness.

Insects May Aid Spread of Fluconazole-Resistant Candida auris
Insects May Aid Spread of Fluconazole-Resistant Candida auris

February 13th 2025

New Virus Discovery Highlights Zoonotic Risks in North America
New Virus Discovery Highlights Zoonotic Risks in North America

February 7th 2025

How Oropouch Fever is Impacting Brazil
How Oropouch Fever is Impacting Brazil

January 28th 2025

Timeline for mRNA Vaccine Development for Rift Valley Fever
Timeline for mRNA Vaccine Development for Rift Valley Fever

January 23rd 2025

Video Series
Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.